Anemia of Prematurity
14
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
88.9%
+2.4% vs benchmark
21%
3 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Iron Supplementation and Intestinal Health
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants
Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants
Near-Infrared Spectroscopy and Cranial Doppler in Premature Newborns With Anemia
Autologous Umbilical Cord Blood Transfusion for Preterm Neonates
The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants
Hepcidin Levels in Preterm Infants
Premature Infants in Need of Transfusion (PINT)
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Autologous Cord Blood Transfusion in Preterm Infants
Early Versus Late Enteral Iron in Infants Less Than 1301 Grams
Neurodevelopment After Early Iron Supplementation